The effect of the selective 5‐HT1A agonists alnespirone (S‐20499) and 8‐OH‐DPAT on extracellular 5‐hydroxytryptamine in different regions of rat brain
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We have examined the effects of the systemic administration of the selective 5‐HT 1A agonist alnespirone (S‐20499) on in vivo 5‐hydroxytryptamine (5‐HT) release in the dorsal raphe nucleus, the median raphe nucleus and four forebrain areas innervated differentially by both (dorsal striatum, frontal cortex, ventral hippocampus and dorsal hippocampus). Alnespirone (0.1–3 mg kg−1, s.c.) dose‐dependently reduced extracellular 5‐HT in the six areas examined. In forebrain, the maximal reductions occurred in striatum and frontal cortex (maximal reduction to 23 and 29% of baseline, respectively). Those in dorsal and ventral hippocampus were more moderate (to ca 65% of baseline). In contrast, the decrease in 5‐HT elicited in the median raphe nucleus was more marked than that in the dorsal raphe nucleus (to ca 30 and 60% of baseline, respectively). The selective 5‐HT 1A antagonist WAY‐100635 (0.5 mg kg−1, s.c.) prevented the decrease in 5‐HT induced by alnespirone (0.3 mg kg−1, s.c.) in frontal cortex. 8‐OH‐DPAT (0.025, 0.1 and 0.3 mg kg−1, s.c.) also reduced extracellular 5‐HT in a regionally‐selective manner (e.g., to 32% of baseline in striatum and to 69% in dorsal hippocampus at 0.1 mg kg−1, s.c.). In midbrain, 8‐OH‐DPAT reduced the dialysate 5‐HT slightly more in the median than in the dorsal raphe nucleus at all doses examined. Doses of both compounds close to their respective ED 50 values (0.3 mg kg−1 alnespirone, 0.025 mg kg−1 8‐OH‐DPAT) reduced 5‐HT to a comparable extent in all regions examined. However, the reductions attained at higher doses were more pronounced for 8‐OH‐DPAT. These data show that the reduction of 5‐HT release elicited by alnespirone and 8‐OH‐DPAT is more important in forebrain areas innervated by 5‐hydroxytryptaminergic neurones of the dorsal raphe nucleus. This regional selectivity seems unlikely to be accounted for by differences in the sensitivity of 5‐HT 1A autoreceptors controlling 5‐HT release, given the dissimilar effects of these two 5‐HT 1A agonists in regions rich in cell bodies and nerve terminals. This suggests the presence of complex mechanisms of control of 5‐HT release by 5‐HT 1A receptors. British Journal of Pharmacology (1997) 122, 733–741; doi:10.1038/sj.bjp.0701420
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070 · cited 1×
“Hippocampal nicotinic heteroreceptors involved in fast synaptic transmission (McGehee et al., 1995) are unlikely to participate, as local administration of nicotine (Toth et al., 1992) or the selective antagonist mecamylamine did not alter the hippocampal 5-HT output (Casanovas & Artigas,…”
BackgroundA PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842 · cited 2×
“…structures by neurones of these two nuclei (Jacobs et al., 1974; Lorens & Guldberg, 1974; Bobilier et al., 1975; Moore & Halaris, 1975; Azmitia & Segal, 1978; KoÈ hler & Steinbusch, 1982; Imai et al., 1986; Kosofsky & Molliver, 1987; Mamounas & Molliver, 1988; Vertes, 1991; McQuade & Sharp, 1997).”
BackgroundBlier, P., Serrano, A., & Scatton, B. (1990) · Synapse · doi:10.1002/syn.890050206 · Cited by 123 · cited 1×
“Initial electrophysiological studies demonstrated a greater sensitivity of DRN neurones to the ®ring-suppressant actions of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) (Sinton & Fallon, 1988; Blier et al., 1990), a view challenged by more recent data (Hajos et al., 1995).”
Result
Cited by
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
Celada, P., Puig, M. V., Amargós-Bosch, M., Adell, A., & Artigas, F. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0427 · Cited by 519
Self-citationCelada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497
“Consistently, 1 M citalopram did not interfere with the local or systemic actions of 5-HT1A receptor ligands on 5-HT release in midbrain or forebrain (Casanovas et al., 1997, 1999; Adell and Artigas, 1998).”
BackgroundSelf-citationGreenwood, B. N., Foley, T. E., Day, H. E. W., Campisi, J., Hammack, S. H., Campeau, S., Maier, S. F., & Fleshner, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02889.2003 · Cited by 367
Celada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs · doi:10.1007/s40263-013-0071-0 · Cited by 323
Self-citationde Boer, S. F., & Koolhaas, J. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.065 · Cited by 318
Metadata
- Authors
- Casanovas, J. M., Lésourd, M., & Artigas, F.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-10
- Volume
- 122
- Issue
- 4
- Pages
- 733-741
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1998113639
- Cited by
- 104
- References
- 3
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of the selective 5‐HT1A agonists alnespirone (S‐20499) and 8‐OH‐DPAT on extracellular 5‐hydroxytryptamine in different regions of rat brain. https://app.cochat.ai/papers/10.1038/sj.bjp.0701420
- The paper
- Casanovas, J. M., Lésourd, M., & Artigas, F. (1997). The effect of the selective 5‐HT1A agonists alnespirone (S‐20499) and 8‐OH‐DPAT on extracellular 5‐hydroxytryptamine in different regions of rat brain. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0701420
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.